Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

被引：0
|
作者：
Chris Skedgel
Daniel Rayson
Tallal Younis
机构：
[1] University of East Anglia,Norwich Medical School
[2] Capital Health,Atlantic Clinical Cancer Research Unit
[3] Capital Health,Department of Medicine
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factors; Economic evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 394
页数：7
相关论文
共 50 条
  • [1] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
    Skedgel, Chris
    Rayson, Daniel
    Younis, Tallal
    SUPPORTIVE CARE IN CANCER, 2016, 24 (01) : 387 - 394
  • [2] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
    Cortes de Miguel, Sol
    Angel Calleja-Hernandez, Miguel
    Menjon-Beltran, Salomon
    Vallejo-Rodriguez, Inmaculada
    SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 547 - 559
  • [3] Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
    Lapidari, Pietro
    Vaz-Luis, Ines
    Di Meglio, Antonio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [4] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
    Sol Cortés de Miguel
    Miguel Ángel Calleja-Hernández
    Salomón Menjón-Beltrán
    Inmaculada Vallejo-Rodríguez
    Supportive Care in Cancer, 2015, 23 : 547 - 559
  • [5] Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer
    Zekri, Jamal
    Nawaz, Azhar
    Rasool, Haleem
    Ahmad, Imran
    Abdel Rahman, Hossam
    Dada, Reyad
    Abdelghany, Ehab Mosaad
    Farag, Kamel
    Ibrahim, Refaei Belal
    Deibas, Mohamed Youssef
    Kamel, Mohamed Kamal
    Allithy, Ahmed
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1681 - 1686
  • [6] A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens
    Zardawi, Sarah J.
    Nordman, Ina
    Zdenkowski, Nicholas
    CANCER REPORTS, 2020, 3 (05)
  • [7] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [8] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Yuri Kimura
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Takayuki Kadoya
    Morihito Okada
    Supportive Care in Cancer, 2021, 29 : 3507 - 3512
  • [9] Cost-Effectiveness of Granulocyte Colony-Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom
    Whyte, Sophie
    Cooper, Katy L.
    Stevenson, Matt D.
    Madan, Jason
    Akehurst, Ron
    VALUE IN HEALTH, 2011, 14 (04) : 465 - 474
  • [10] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    Kelly, S.
    Wheatley, D.
    BRITISH JOURNAL OF CANCER, 2009, 101 : S6 - S10
12345